| tumour angiogenic factor | A substance released by solid tumours which induces formation of new blood vessels to supply the tumour. (05 Mar 2000) |
|---|
| angiogenic | 1. Relating to angiogenesis. 2. Of vascular origin. (05 Mar 2000) |
|---|---|
| p60 tumour necrosis factor receptor-associated kinase | <enzyme> Interacts with and causes phosphorylation of the cytoplasmic domain of the tnf receptor Registry number: EC 2.7.10.- Synonym: p60 tnf receptor-associated kinase, p60-trak (26 Jun 1999) |
| receptors, tumour necrosis factor | Cell surface receptors that bind tumour necrosis factor and trigger changes which influence the behaviour of cells. The two recognised tumour necrosis factor receptors are designated alpha and beta receptors. Both receptors bind both alpha and beta tumour necrosis factors with high affinity, and both are members of the nerve growth factor receptor family. (12 Dec 1998) |
| tumour angiogenesis factor | <growth factor> Substance released from a tumour that promotes vascularisation of the mass of neoplastic cells. Once a tumour becomes vascularised, it will grow more rapidly and is more likely to metastasise. TAF is almost certainly more than one substance. See: angiogenin. (18 Nov 1997) |
| tumour necrosis factor | <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin. Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine. Synonym: cachectin. Acronym: TNF (13 Nov 1997) |
| tumour necrosis factor-beta | <cytokine> A cytolytic factor that is produced by CD4 and CD8 T-cells after their exposure to an antigen. (05 Mar 2000) |
| acinar cell tumour | A solid and cystic tumour of the pancreas, occurring in young women; tumour cells contain zymogen granules. (05 Mar 2000) |
| acute splenic tumour | Acute splenitis, enlargement, and softening of the spleen, usually due to bacteraemia or severe bacterial toxaemia. (05 Mar 2000) |
| adenoid tumour | Adenoma, or neoplasm with glandlike spaces. (05 Mar 2000) |
| adenomatoid odontogenic tumour | A benign epithelial odontogenic tumour appearing radiographically as a well-circumscribed radiolucent-radiopaque lesion usually surrounding the crown of an impacted tooth in an adolescent or young adult; characterised histologically by columnar cells organised in a duct-like configuration interspersed with spindle-shaped cells and amyloid-like deposition that gradually undergoes dystrophic calcification. Synonym: adenoameloblastoma, ameloblastic adenomatoid tumour. (05 Mar 2000) |
| adenomatoid tumour | A small, circumscribed, benign tumour of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (12 Dec 1998) |
| adipose tumour | <oncology, tumour> Clumps of fat cells. Literally, fat cancer. These are benign tumours that can form in the breast. (16 Dec 1997) |
| adrenal gland tumour | <oncology> A benign tumour or adenoma, that usually results in the excess production of adrenal gland hormones. (27 Sep 1997) |
| adrenal rest tumour | A rare, usually benign, ovarian tumour thought to be derived from embryonic rest cells of the adrenals. This tumour causes various degrees of masculinization. (12 Dec 1998) |
| ameloblastic adenomatoid tumour | A benign epithelial odontogenic tumour appearing radiographically as a well-circumscribed radiolucent-radiopaque lesion usually surrounding the crown of an impacted tooth in an adolescent or young adult; characterised histologically by columnar cells organised in a duct-like configuration interspersed with spindle-shaped cells and amyloid-like deposition that gradually undergoes dystrophic calcification. Synonym: adenoameloblastoma, ameloblastic adenomatoid tumour. (05 Mar 2000) |